Colgate-Palmolive Co (CL) FinancialsCLColgate-Palmolive Co

Colgate-Palmolive Company (CL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Oral, Personal and Home Care, accounting for 77.7% of total sales, equivalent to $4.17B. Another important revenue stream is Pet Nutrition. Understanding this composition is critical for investors evaluating how CL navigates market cycles within the Personal Products industry.

Evaluating the bottom line, Colgate-Palmolive Company maintains a gross margin of 61.03%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 21.20%, while the net margin is 13.11%. These profitability ratios, combined with a Return on Equity (ROE) of 434.54%, provide a clear picture of how effectively CL converts its operational activities into shareholder value.

In the context of the broader market, CL competes directly with industry leaders such as UL and EL. With a market capitalization of $73.96B, it holds a significant position in the sector. When comparing efficiency, CL's gross margin of 61.03% stands against UL's 100.00% and EL's 75.60%. Such benchmarking helps identify whether Colgate-Palmolive Company is trading at a premium or discount relative to its financial performance.

Colgate-Palmolive has demonstrated solid financial performance with a gross margin of 61.48% in Q2 2026 and a net income of $693 million in the same quarter. The company has maintained a consistent dividend growth streak for 63 years, showcasing its stability and commitment to returning value to shareholders.